Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

by Ostenson CG, Matthaei S, Reaney M, Krarup T, Guerci B, Kiljanski J, Salaun-Martin C, Sapin H, Bruhn D, Mathieu C, Theodorakis M
Published 2013-04-01

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

by Kiiskinen U, Matthaei S, Reaney M, Mathieu C, Östenson C-G, Krarup T, Theodorakis M, Kiljański J, Salaun-Martin C, Sapin H, Guerci B
Published 2013-07-01